These wonder drugs developed originally as a therapeutic tool for diabetes (and coupled with a healthful diet theyre a good one for that) are famously now being employed for weight loss in the broader non-diabetic (and sometimes not even particularly overweight) population, but also for a crazy quilt array of other conditions, including: cardiovascular risk reduction (for which theyve gained FDA approval), obstructive sleep apnea tied to obesity, slowing the progression of chronic kidney disease, improving fatty liver disease, protecting against Alzheimers and other dementias, and such off label applications as reducing the craving for alcohol and other addictive substances, lowering blood pressure, improving lipid profiles, increasing insulin sensitivity in PCOS, and possible roles in alleviating chronic pain, strengthening bones in osteoporosis, and reducing seizures
The plasma level of GHK is about 200 ng/ml at age 20 but declines to 80 ng/ml by age 60
The United States Food and Drug Administration (USFDA) have recommended H
Nevertheless, these therapies frequently have unfavorable impacts and fail to effectively address the metabolic issues linked to RA, such as oxidative stress and dyslipidemia 7